Below are the financial statements of Biocon, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in billions of INR | 2025 | 2024 |
|---|---|---|
| Income | — | — |
| Revenue from operations | 152.62a | 147.56a |
| Other income | 12.08a | 8.66a |
| Total income | 164.7a | 156.21a |
| Expenses | — | — |
| Cost of materials consumed | -42.77a | -50.72a |
| Purchases of stock-in-trade | -6.27a | -6.83a |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | -2.94a | -8.57a |
| Employee benefits expense | -31.44a | -26.64a |
| Finance costs | -8.97a | -9.74a |
| Depreciation and amortisation expense | -16.87a | -15.69a |
| Other expenses | -39.01a | -39.79a |
| Less: Recovery of cost from co-development partners (net) | -1.48a | -0.84a |
| Total expenses | -146.8a | -140a |
| Profit before tax, share of profit/(loss) of joint venture and associates and exceptional items | 17.9a | 16.21a |
| Share of loss of joint venture and associates (net) | 0a | -0.84a |
| Profit before tax and exceptional items | 17.9a | 15.37a |
| Exceptional items (net) | 0.97a | -0.12a |
| Profit before tax | 18.87a | 15.25a |
| Tax expense | — | — |
| Current tax | -3.69a | -3.14a |
| Deferred tax (credit) / charge | — | — |
| MAT credit written off/ utilisation (net of entitlements) | -0.55a | -0.77a |
| Other deferred tax | -0.33a | -0.1a |
| Total tax expense | -4.57a | -2.27a |
| Profit for the year | 14.29a | 12.98a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biocon’s data sources below and access millions more through our Disclosure Search.